You are here: Industry Insights > SARS-CoV-2

News List

New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory prnewswire
February 01, 2021
A paper was published by Dr. Steven Quay, M.D., PhD., CEO of Atossa Therapeutics, Inc., entitled, "A Bayesian analysis concludes beyond a reasonable doubt that SARS-CoV-2 is not a natural zoonosis but instead is laboratory derived."
AstraZeneca COVID-19 Vaccine Recommended for use in the EU americanpharmaceuticalreview
February 01, 2021
AstraZeneca’s COVID-19 vaccine has been recommended for conditional marketing authorization (CMA) in the European Union (EU) for active immunization to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.
UK will offer its genomic expertise worldwide to identify new COVID-19 variants pharmatimes
January 29, 2021
The UK will offer its genomic expertise to the international community with the aim of aiding the identification of new variants of COVID-19, the government has announced.
Gravity Diagnostics Coordination with Kentucky Department of Health Leads to Findings of First Cases of UK COVID-19 Variant Identified in the State prnewswire
January 29, 2021
On Tuesday, January 26th, Governor Andy Beshear's office announced that the first two cases of a more contagious variant of coronavirus, first identified in the United Kingdom, have been confirmed in Kentucky.
OncoSec Announces First Subjects Dosed in Phase 1 Trial of COVID-19 Vaccine americanpharmaceuticalreview
January 28, 2021
OncoSec Medical Incorporated has dosed several subjects in its Phase 1 clinical trial of CORVax12, the only vaccine candidate to include an immunostimulatory cytokine to address COVID-19.
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program prnasia
January 26, 2021
BioVaxys Technology Corp. is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021.
ConserV Bioscience, LLNL to Collaborate on Development of Broad-spectrum Coronavirus Vaccine americanpharmaceuticalreview
January 25, 2021
ConserV Bioscience Limited and Lawrence Livermore National Laboratory (LLNL) have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine.
SML Genetree Receives EUA for Ezplex SARS-CoV-2 G Real-Time PCR Kit americanpharmaceuticalreview
January 22, 2021
SML Genetree has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the use of its Ezplex SARS-CoV-2 G Kit, a molecular diagnostic test for the qualitative detection of RNA from SARS-CoV-2 from ...
COVID-19 has multiple faces worldpharmanews
January 21, 2021
According to current studies, the COVID-19 disease which is caused by the SARS-CoV-2 coronavirus comprises at least five different variants.
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing prnasia
January 21, 2021
LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page